EverGlade Insights Blog
EverGlade Consulting (“EverGlade”), a Washington, D.C. based consulting firm, has successfully aided Detect, Inc. (“Detect”) in securing a contract with BARDA for the advanced development of a next-generation diagnostic device which is an over-the-counter home...
With BARDA Industry Day kicking off on November 3, 2021, new opportunities abound for organizations supporting the pandemic response. These include an updated BARDA Broad Agency Announcement (“BAA”), a new Commercial Solutions Opening (“CSO”) from...
One must only think back to the spring of 2020 to remember the constant barrage of news coverage of doctors and nurses using garbage bags as medical gowns and improvised masks. America was caught completely...
On Friday, September 3, 2021, the White House released its much-anticipated pandemic preparedness plan. This detailed 27-page document lays out a 10-year vision that will centralize efforts currently spread across a myriad of agencies, into...
It seems that there may be a new Valley of Death on the horizon of COVID therapeutic development. Earlier this month (9 JUL) NIAID posted a Funding Opportunities Announcement soliciting proposals related to COVID therapeutic...
Earlier this month the Army Contracting Command published an amendment to solicitation W911QY-20-S-C001 related to Area of Interest 5, oral antiviral therapeutics. This is a procurement solicitation and specifically the USG is looking for direct-acting...